hVIVO (HVO) Competitors

Ergomed (LON:ERGO) and hVIVO (LON:HVO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, community ranking, valuation, earnings and profitability.

Which has better valuation & earnings, ERGO or HVO?

hVIVO has lower revenue, but higher earnings than Ergomed. hVIVO is trading at a lower price-to-earnings ratio than Ergomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ergomed	£152.09M	4.61	£15M	£0.29	4,641.38
hVIVO	£58.67M	3.35	£16.11M	£0.02	1,445.00

Does the media refer more to ERGO or HVO?

In the previous week, hVIVO's average media sentiment score of 0.59 beat Ergomed's score of 0.00 indicating that hVIVO is being referred to more favorably in the news media.

Company	Overall Sentiment
Ergomed	Neutral
hVIVO	Positive

Does the MarketBeat Community favor ERGO or HVO?

Ergomed received 119 more outperform votes than hVIVO when rated by MarketBeat users. Likewise, 75.63% of users gave Ergomed an outperform vote while only 69.89% of users gave hVIVO an outperform vote.

Company	Underperform	Outperform
Ergomed	Outperform Votes 242 75.63%	Underperform Votes 78 24.38%
hVIVO	Outperform Votes 123 69.89%	Underperform Votes 53 30.11%

Do analysts rate ERGO or HVO?

Ergomed currently has a consensus target price of GBX 1,350, indicating a potential upside of 0.30%. Given Ergomed's higher probable upside, equities analysts plainly believe Ergomed is more favorable than hVIVO.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ergomed	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
hVIVO	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Do institutionals & insiders have more ownership in ERGO or HVO?

71.1% of Ergomed shares are held by institutional investors. Comparatively, 26.4% of hVIVO shares are held by institutional investors. 18.2% of Ergomed shares are held by company insiders. Comparatively, 38.3% of hVIVO shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Is ERGO or HVO more profitable?

hVIVO has a net margin of 27.47% compared to Ergomed's net margin of 9.87%. hVIVO's return on equity of 59.09% beat Ergomed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ergomed	9.87%	18.08%	10.16%
hVIVO	27.47%	59.09%	9.58%

Which has more risk and volatility, ERGO or HVO?

Ergomed has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, hVIVO has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500.

Summary

Ergomed beats hVIVO on 9 of the 15 factors compared between the two stocks.